on the brink?, page-20

Liao,

Like I said, from a risk capital point of view the pside is tremendous if you acknowledge and accept, that with little sales its possible the company goes belly up and the IP gets sold for a song.

As I said i am intrigued by the company and rationalised that it is worth some risk capital. If I lose it it';s no sweat.

I like the story and I liked teh story when HTX was 20 cents. But that IP needs to be monetised. Also would lvoe to hear from any holders who are au fait with the IP side of things.....from memory biomarkers in and of themselves cannot be patented and it is the diagnostic process that the IP relates to...

Any thoughts, feedback, input welcome.